| Factor Information | |
|---|---|
| Data ID | 2966 |
| Factor | prevalence of hyponatraemia in NYHA class |
| Description | N/A |
| Biomarker | NA |
| Classification | A3 (clinical factor - disease & symptom) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | prognostic implications of hyponatraemia in ACHD |
| p Value | 0.049 |
| OR | 1.61 |
| Conclusion | The risk of hyponatraemia was higher among patients with moderate or severe function impairement(NYHA class 3-4). |
| Risk Factor | risk factor |
| CHD Type | |
|---|---|
| ID | 642 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | ASD/VSD/AVSD/AC/TOF/TGA/ACHD |
| Reference | |
|---|---|
| PMID | 19933692 |
| Year | 2010 |
| Title | Hyponatraemia: a strong predictor of mortality in adults with congenital heart disease |
| Sample | ||
|---|---|---|
| Population | adults | |
| Source | patients' data | |
| Region | London, UK | |
| Method | univariable analysis logsitic regression | |
| Race | British | |
| Disease History | N/A | |
| Treatment History | previous repair surgery | |
| Group | ACHD with sodium <136mmol/L,NYHA class 3-4 patienst(Treatment) | ACHD with sodium <136mmol/L,NYHA class 1 patients(Control) |
| Number | 31 | 90 |
| Age | 37.4±15.8 | 35.9±14.1 |
| Gender (Male: Female) | 73:83 | 416:432 |
| Marker Level | 21.7%(NYHA class 3-4 patienst) | 14.6%(NYHA class 1 patients) |
